News & Perspective

Dec 06, 2011

Dec 06, 2011

Mapping studies show scope of P vivax malaria burden

(CIDRAP News) – Though global rates of the most deadly form of malaria are declining in Africa, the parasite's less deadly but more difficult-to-treat cousin, Plasmodium vivax, has a firm foothold in many parts of South Asia and Latin America, according to new mapping studies.

Nov 17, 2015

Nov 17, 2015
Fog and flood

WHO says health impacts of climate change overlooked

Earlier this week, a leading expert voiced similar concerns, noting that the WHO hadn't made its voice heard.

Jan 18, 2019

Jan 18, 2019
Plasmodium in bloodstream

New one-dose drug prevents malaria relapse, studies show

A total of 62.4% of patients taking tafenoquine were free of P vivax after 6 months.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»